Search clinical trials for: Intermediate-2 Myelodysplastic syndrome
Total 82086 results
-
Onconova Therapeutics, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
Samsung Medical CenterCompletedMajor Depressive DisorderKorea, Republic of
-
Norwegian University of Science and TechnologyCompleted
-
Astex Pharmaceuticals, Inc.CompletedAML | MDS | CMMLUnited States, Canada
-
Salzburger LandesklinikenCompletedIntermediate Cervical Plexus Block for Carotid EndarterectomyAustria
-
North-West University, South AfricaMedical Research Council, South Africa; National Research Foundation of South... and other collaboratorsCompletedMalnutrition | Vitamin A Status | Iron Status | Zinc StatusSouth Africa
-
Helsinn Healthcare SACompletedMyelodysplastic SyndromeUnited States
-
Genzyme, a Sanofi CompanyCompletedMyelodysplastic Syndromes | Secondary Acute Myeloid Leukemia (AML)United States
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedMalnutrition | Cognition Disorders | Mood Disorder | Gait Disorder, NeurologicNetherlands
-
Democritus University of ThraceUnknownPresbyopia | Astigmatism | Myopia | HyperopiaGreece
-
Kuwait UniversityUniversity of TurkuCompleted
-
University of ManitobaCompleted
-
University of EdinburghUniversity of PeradeniyaCompletedOrganophosphate PoisoningSri Lanka
-
Sumitomo Pharma America, Inc.TerminatedAnemia in Myelodysplastic SyndromesUnited States
-
RWTH Aachen UniversityCompleted
-
University of MichiganCompletedThe Study is Intended to Increase Take-up of EITCUnited States
-
Giriraj HospitalCompletedStudy to Know the Efficacy of Higher Doses of Pralidoxime in Patients of Organophpsphorus Poisoning.Acute Organophosphorus Pesticide PoisoningIndia
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...CompletedNon Muscle Invasive Bladder Cancer
-
Brigham and Women's HospitalCompletedKnown CAD, or Intermediate-high Pretest Likelihood for CADUnited States, Canada
-
Onconova Therapeutics, Inc.Withdrawn
-
Guangzhou HuiBoRui Biological Pharmaceutical Technology...ParexelUnknownCorneal NeovascularizationUnited States
-
China National Center for Cardiovascular DiseasesUnknownCoronary Angiography | Coronary AtherosclerosesChina
-
St. Franziskus HospitalCompleted
-
University of AarhusCompleted
-
Imperial College LondonThe Health FoundationCompleted
-
Weizmann Institute of ScienceHadassah Medical OrganizationRecruitingDietary Fibers | Intermediate FastingIsrael
-
EyePoint Pharmaceuticals, Inc.CompletedPanuveitis | Posterior Uveitis | Intermediate UveitisIndia
-
Johns Hopkins UniversityMacuSight, Inc.CompletedPanuveitis | Uveitis | Posterior Uveitis | Intermediate UveitisUnited States
-
Henry Ford Health SystemCompleted
-
University Hospitals, LeicesterWarwick Medical SchoolCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
Priovant Therapeutics, Inc.Active, not recruitingNon-infectious Intermediate Uveitis | Non-infectious Posterior Uveitis | Non-infectious Pan UveitisUnited States
-
FibroGenAstraZeneca; Astellas Pharma IncTerminatedPrimary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)United States, Australia, Belgium, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, France, Turkey, Canada, Denmark, India, Poland
-
Tufts Medical CenterFisher and Paykel HealthcareCompletedAcute Respiratory Failure | Treatment With Noninvasive Positive Pressure VentilationUnited States
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalRecruiting
-
Duke UniversityCompletedPosterior Uveitis | Intermediate UveitisUnited States
-
AllerganCompletedPosterior Uveitis | Intermediate UveitisFrance, United Kingdom, United States, Spain, Poland, India, South Africa, Korea, Republic of, Canada, Czech Republic, Australia, Germany, Israel, Switzerland, Portugal, Austria, Brazil, Greece
-
Mahidol UniversityCompletedThyroid Nodule | Parathyroid AdenomaThailand
-
Rigshospitalet, DenmarkCompletedSedentary Lifestyle | Overweight and Obesity | Metabolic DiseaseDenmark
-
Mersin UniversityRecruiting
-
Zagazig UniversityUnknownSecond Trimester AbortionEgypt
-
University of NebraskaUnknownPosterior Uveitis | Intermediate Uveitis | Pan-uveitisUnited States
-
Novartis PharmaceuticalsCompletedNon-infectious Intermediate Uveitis | Non-infectious Posterior Uveitis | Non-infectious PanuveitisUnited States, United Kingdom
-
Akdeniz UniversityRecruiting
-
Stanford UniversitySanten Inc.WithdrawnPanuveitis | Uveitis | Posterior Uveitis | Intermediate UveitisUnited States
-
Weill Medical College of Cornell UniversitySunesis PharmaceuticalsCompletedVosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based TherapyMyelodysplastic SyndromeUnited States
-
Mansoura UniversityCompleted
-
CHU de Quebec-Universite LavalCompletedIntermediate Uveitis | Anterior UveitisCanada
-
Samsun UniversityRecruiting
-
Istanbul Medipol University HospitalCompletedPregnancy Complications | ChronotypeTurkey